Occurrence of implantable cardioverter-defibrillator therapy in
clinical practice

J 2017

Occurrence of implantable cardioverter-defibrillator therapy in clinical practice

NAGY, Andrej, Jolana LIPOLDOVÁ, Miroslav NOVÁK a Radka ŠTĚPÁNOVÁ

Základní údaje

Originální název

Occurrence of implantable cardioverter-defibrillator therapy in clinical practice

Autoři

NAGY, Andrej (703 Slovensko, garant, domácí), Jolana LIPOLDOVÁ (203 Česká republika, domácí), Miroslav NOVÁK (203 Česká republika, domácí) a Radka ŠTĚPÁNOVÁ (203 Česká republika, domácí)

Vydání

Cor et Vasa, AMSTERDAM, ELSEVIER SCIENCE BV, 2017, 0010-8650

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Kód RIV

RIV/00216224:14110/17:00098523

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.crvasa.2016.12.014

UT WoS

000410032200001

Klíčová slova anglicky

ICD; Ventricular fibrillation; Ventricular tachycardia; Remote monitoring; SCD predictors; Programmed ventricular stimulation

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 28. 1. 2021 11:29, Mgr. Tereza Miškechová

Anotace

V originále

The landmark trials MADIT II, SCD-HeFT, and COMPANION in 2002-2005 years have reported their positive results to sudden cardiac death reduction. Since that time the indications for the use of implantable cardioverter-defibrillators (ICDs) have substantially broadened. The occurrence of appropriate ICD therapy differs in the individual trials. We were retrospectively analyzing the occurrence of ventricular tachycardia/ventricular fibrillation (VT/VF) from ICD remote monitoring database (Biotronik Home Monitoring TM, www.biotronik-homemonitoring.com). No significant difference was found between subgroups divided by the implantation indication, the programmed ventricular stimulation, the aggressivity of programmed ventricular stimulation protocol, left ventricular ejection fraction, ICD types, percentage of right ventricular pacing, diabetes mellitus, renal dysfunction and gender. VT/VF occurred statistically significantly more often in patients with non-sustained VT on the preimplant Holter monitoring report in patients with primary preventive indication for postinfarction coronary artery disease but not in primary preventive indication for non-ischemic dilated cardiomyopathy. We observed higher VT/VF occurrence in patients with preimplant syncope or presyncope even higher than in patients after cardiopulmonary resuscitation. There was a visible trend for higher VT/VF occurrence in patients with positive programmed ventricular stimulation especially with less aggressive protocol and in patients with left ventricular ejection fraction of 30% and less. Authors found the preimplant nonsustained ventricular tachycardia (NSVT) on Holter monitoring as the only independent predictor of VT/VF occurrence. (C) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. zo.o. All rights reserved.

Návaznosti

LM2015090, projekt VaV

Název: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu

Citovat

NAGY, Andrej, Jolana LIPOLDOVÁ, Miroslav NOVÁK a Radka ŠTĚPÁNOVÁ. Occurrence of implantable cardioverter-defibrillator therapy in clinical practice. Cor et Vasa. AMSTERDAM: ELSEVIER SCIENCE BV, 2017, roč. 59, č. 3, s. "E215"-"E221", 7 s. ISSN 0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2016.12.014.

@article{1397072,
   author = {Nagy, Andrej and Lipoldová, Jolana and Novák, Miroslav and Štěpánová, Radka},
   article_location = {AMSTERDAM},
   article_number = {3},
   doi = {http://dx.doi.org/10.1016/j.crvasa.2016.12.014},
   keywords = {ICD; Ventricular fibrillation; Ventricular tachycardia; Remote monitoring; SCD predictors; Programmed ventricular stimulation},
   language = {eng},
   issn = {0010-8650},
   journal = {Cor et Vasa},
   title = {Occurrence of implantable cardioverter-defibrillator therapy in clinical practice},
   url = {http://dx.doi.org/10.1016/j.crvasa.2016.12.014},
   volume = {59},
   year = {2017}
}

TY  - JOUR
ID  - 1397072
AU  - Nagy, Andrej - Lipoldová, Jolana - Novák, Miroslav - Štěpánová, Radka
PY  - 2017
TI  - Occurrence of implantable cardioverter-defibrillator therapy in clinical practice
JF  - Cor et Vasa
VL  - 59
IS  - 3
SP  - "E215"-"E221"
EP  - "E215"-"E221"
PB  - ELSEVIER SCIENCE BV
SN  - 00108650
KW  - ICD
KW  - Ventricular fibrillation
KW  - Ventricular tachycardia
KW  - Remote monitoring
KW  - SCD predictors
KW  - Programmed ventricular stimulation
UR  - http://dx.doi.org/10.1016/j.crvasa.2016.12.014
L2  - http://dx.doi.org/10.1016/j.crvasa.2016.12.014
N2  - The landmark trials MADIT II, SCD-HeFT, and COMPANION in 2002-2005 years have reported their positive results to sudden cardiac death reduction. Since that time the indications for the use of implantable cardioverter-defibrillators (ICDs) have substantially broadened. The occurrence of appropriate ICD therapy differs in the individual trials. We were retrospectively analyzing the occurrence of ventricular tachycardia/ventricular fibrillation (VT/VF) from ICD remote monitoring database (Biotronik Home Monitoring TM, www.biotronik-homemonitoring.com). No significant difference was found between subgroups divided by the implantation indication, the programmed ventricular stimulation, the aggressivity of programmed ventricular stimulation protocol, left ventricular ejection fraction, ICD types, percentage of right ventricular pacing, diabetes mellitus, renal dysfunction and gender. VT/VF occurred statistically significantly more often in patients with non-sustained VT on the preimplant Holter monitoring report in patients with primary preventive indication for postinfarction coronary artery disease but not in primary preventive indication for non-ischemic dilated cardiomyopathy. We observed higher VT/VF occurrence in patients with preimplant syncope or presyncope even higher than in patients after cardiopulmonary resuscitation. There was a visible trend for higher VT/VF occurrence in patients with positive programmed ventricular stimulation especially with less aggressive protocol and in patients with left ventricular ejection fraction of 30% and less. Authors found the preimplant nonsustained ventricular tachycardia (NSVT) on Holter monitoring as the only independent predictor of VT/VF occurrence. (C) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. zo.o. All rights reserved.
ER  -

NAGY, Andrej, Jolana LIPOLDOVÁ, Miroslav NOVÁK a Radka ŠTĚPÁNOVÁ. Occurrence of implantable cardioverter-defibrillator therapy in clinical practice. \textit{Cor et Vasa}. AMSTERDAM: ELSEVIER SCIENCE BV, 2017, roč.~59, č.~3, s.~''E215''-''E221'', 7 s. ISSN~0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2016.12.014.

Podrobný výpis o publikaci